Experimental Hematology

杂志介绍

Experimental Hematology杂志介绍

《Experimental Hematology》是一本以English为主的未开放获取国际优秀期刊，中文名称实验血液学，本刊主要出版、报道医学-血液学领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCI、SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.7，最新CiteScore 指数为4。

本刊近期中国学者发表的论文主要有：

• Heme synthesis inhibition induces the intrinsic apoptosis pathway in leukemia with OSGIN1 upregulatio

  Author: Yan, Yan; Kato, Hiroki; Sano, Sayaka; Furukawa, Eijiro; Ichikawa, Satoshi; Onodera, Koichi; Onishi, Yasushi; Fukuhara, Noriko; Yokoyama, Hisayuki; Fujiwara, Tohru; Harigae, Hideo

• Analysis of risk factors for early death of lymphocyte subsets in adult patients with secondary hemophagocytic lymphohistiocytosi

  Author: Ling, Xiaosui; Chen, Heng; Zhang, Xiuqin; Xu, Tangxing; Deng, Aigen; Yang, Jing

• Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtype

  Author: Lu, Jiawen; Xue, Xiuhua; Wang, Haitao; Hao, Ying; Yang, Qiong

• Large-scale mediator Mendelian randomization the causal link between gut microbes and chronic graft-versus-host disease ris

  Author: Chen, Yiyin; Yu, Xinghao; Cai, Yiming; Jin, Zhou; Xu, Yang

英文介绍

Experimental Hematology杂志英文介绍

Experimental Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation on a monthly basis that may include Special Issues on particular topics of current interest. The overall goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment. Specific topics may include relevant developmental and aging processes, stem cell biology, analyses of intrinsic and extrinsic regulatory mechanisms, in vitro behavior of primary cells, clonal tracking, molecular and omics analyses, metabolism, epigenetics, bioengineering approaches, studies in model organisms, novel clinical observations, transplantation biology and new therapeutic avenues.